Tag Archives: Market

The site management organizations (SMO) market

The Site Management Organizations Market report features an extensive study of the current market landscape and future potential of the site management organizations market. rnrnRoots Analysis has announced the addition of “Site Management Organizations (SMO) Market, 2021 – 2035” report to its list of offeringsrnrnIn recent years, drug / device developers have demonstrated a preference to continue relying on SMOs for conducting clinical trials in order to significantly optimize trial cost and research timelines. Driven by the steady growth in clinical research activity and inherent benefits offered by SMOs, the market opportunity for such players is projected to grow at a significant pace in the foreseen future.rnrnTo order this 270+ page report, which features 95+ figures and 120+ tables, please visit rnhttps://www.rootsanalysis.com/reports/site-management-organizations-market.html rnrnKey Market Insights rnrnAround 250 companies across the world claim to offer clinical trial site management services rnMajority (43%) of the industry stakeholders are headquartered in North America, followed by those based in Asia-Pacific (32%) and Europe (19%). In addition, 25% of the companies engaged in this domain offer site management services across the globe, followed by those providing services in Asia-Pacific (23%).rnrn200+ partnerships were established in this domain, during the period 2016-2021rnService alliances (26%) and clinical trial agreements (23%) emerged as the most common types of partnership models adopted by stakeholders engaged in this domain. Nearly 65% of the deals in this domain were established after 2018, with the maximum activity being reported in 2021 (56). rnrn~USD 1 billion invested in various domain focused initiatives, since 2015 rnMaximum number of funding instances (21%) were reported in 2021, amounting to USD 614 million in capital investments. A significant number of funding instances (43%) were venture capital rounds, followed by instances of other equity (29%) and grants (7%). rnrnrnTo request a sample copy / brochure of this report, please visit rnhttps://www.rootsanalysis.com/reports/site-management-organizations-market.htmlrnrnKey Questions Answeredrn Who are the leading players engaged in the clinical trial site management domain?rn What is the relative competitiveness of different site management organizations?rn What type of partnership models are commonly adopted by stakeholders in this industry?rn What is the capital investments trend in the site management organizations domain?rn Which are the most active clinical trial centers?rn What are the major market trends and driving factors that are likely to impact the growth of site management organizations market?rn How is the current and future market opportunity likely to be distributed across key market segments?rnrnThe report also features inputs from eminent industry stakeholders, according to whom, complexities associated with clinical trial processes and increasing clinical pipeline will drive the growth of the third-party service providers, such as SMOs, engaged in this domain, in the coming future. The report includes detailed transcripts of discussions held with the following experts:rn Vinod Gyanchandani (Country Head – Clinical Operations, GDD Experts)rn Marisa Vico (Medical Director and Operations Manager, SMO – Dra. Marisa Vico)rn Eugene Winifred (Project Manager, Syncretic Clinical Research Services)rnrnrnFor additional details, please visit rnhttps://www.rootsanalysis.com/reports/site-management-organizations-market.htmlrnor email [email protected] rnrnYou may also be interested in the following titles: rn1. Patient Recruitment and Retention Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030rn2. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030rn3. Clinical Trial Planning and Design Services Market: Industry Trends and Global Forecasts, 2021-2030rn4. Biospecimen Contract Research Services Market: Industry Trends and Global Forecast, 2021-2030rn5. Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030rnrnAbout Roots AnalysisrnRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] InformationrnRoots Analysis Private LimitedrnBen Johnsonrn+1 (415) 800 3415rn+44 (122) 391 [email protected] https://www.rootsanalysis.com/reports/site-management-organizations-market.html

The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%, claims Roots Analysis

Roots Analysis has announced the addition of “CD-47 Targeting Therapeutics Market, 2021-2035” report to its list of offerings.rnrnIn recent years, the focus of the research community has shifted towards the development of novel treatment modalities, such as T- cell immunotherapies, that exhibit high efficacy. CD-47, owing to its increased expression on the surface of cancer cells, has emerged as a cancer immune checkpoint biomarker. rnrnTo order this 190+ page report, which features 142+ figures, please visit https://www.rootsanalysis.com/reports/cd-47-targeting-therapeutics-market.htmlrnrnKey Market InsightsrnrnOver 75 CD-47 drug candidates are under various phases of development rn52% of the pipeline candidates are currently in preclinical and discovery stages, while more than 48% therapies are being evaluated in clinical stages with most candidates being in early clinical stages (41.6%); 3.9% and 2.6% of clinical candidates being evaluated in phase II and phase III respectively.rnrn~50 companies claim to be engaged in the development of CD-47 therapeutics, globallyrnSince 2015, 13 companies have been established in this domain. Further, around 44% of the industry stakeholders are small companies. In addition, majority (47%) of the CD-47 therapeutics developers are based in North America, primarily in the US.rnrnSeveral clinical trials evaluating CD-47 targeting therapeutics have been registered worldwidernClinical research activity, in terms of number of trials registered, is reported to have increased at a CAGR of 34.1%, during the period 2015-2020. Of the total, close to 13% of the studies have already been completed, followed by active trials that are actively recruiting patients (46.7%).rnrnTo request a sample copy / brochure of this report, please visit rnhttps://www.rootsanalysis.com/reports/cd-47-targeting-therapeutics-market.htmlrnrnFor additional details, please visit rnhttps://www.rootsanalysis.com/reports/cd-47-targeting-therapeutics-market.html or email [email protected] rnrnYou may also be interested in the following titles: rn1. RAS Targeting Therapies Market, 2021-2031rn2. Squamous NSCLC Market, 2021-2031rn3. Peptide Therapeutics Market, 2021-2031rnrnAbout Roots AnalysisrnRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]:rnBen Johnsonrn+1 (415) 800 3415rn+44 (122) 391 [email protected] – https://www.facebook.com/RootsAnalysisrnLinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/rnTwitter – https://twitter.com/RootsAnalysisrnMedium – https://medium.com/@RootsAnalysisrnPinterest – https://in.pinterest.com/RootsanalysisPin/_saved/rnQuora – https://rootsanalysisinsights.quora.com/rn https://www.rootsanalysis.com/reports/cd-47-targeting-therapeutics-market.html

The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis

Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”rnrnThe report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes:rn A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals. rn A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers across various packaging types.rn Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific).rn An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics.rn A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios.rn A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations.rn A discussion on the potential growth areas and recent trends impacting the outsourcing potential for biopharmaceuticals.rnrnKey companies covered in the reportrn Advanced BioScience Laboratories (ABL)rn Albany Molecular Research (AMRI)rn Bioconrn BioPharma Solutionsrn BioReliancern Boehringer Ingelheim BioXcellencern ChemPartnerrn Emergent BioSolutionsrn IDT Biologikarn Lonzarn LuinaBiorn Mycenax Biotechrn Patheonrn Recipharmrn Vetter Pharmarn WuXi BiologicsrnrnFor more information please click on the following link:rnhttps://www.rootsanalysis.com/reports/view_document/biologics-fill–finish-services-market-2019-2030/256.html rnrnOther Recent Offeringsrn1. Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030rn2. Medical Device Contract Manufacturing Market, 2019-2030rn3. Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closuresrn4. Biopharma Contract Manufacturing Market (3rd Edition), 2019 – 2030rn5. Patient Recruitment and Retention Services Market, 2019-2030rnrnAbout Roots AnalysisrnRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] InformationrnRoots Analysis Private LimitedrnGaurav Chaudharyrn+1 (415) 800 3415rngaurav.chaudh[email protected] https://www.rootsanalysis.com/reports/view_document/biologics-fill–finish-services-market/256.html

The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis

Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”rnrnThe report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes:rn A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals. rn A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers across various packaging types.rn Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific).rn An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics.rn A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios.rn A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations.rn A discussion on the potential growth areas and recent trends impacting the outsourcing potential for biopharmaceuticals.rnrnKey companies covered in the reportrn Advanced BioScience Laboratories (ABL)rn Albany Molecular Research (AMRI)rn Bioconrn BioPharma Solutionsrn BioReliancern Boehringer Ingelheim BioXcellencern ChemPartnerrn Emergent BioSolutionsrn IDT Biologikarn Lonzarn LuinaBiorn Mycenax Biotechrn Patheonrn Recipharmrn Vetter Pharmarn WuXi BiologicsrnrnFor more information please click on the following link:rnhttps://www.rootsanalysis.com/reports/view_document/biologics-fill–finish-services-market-2019-2030/256.html rnrnOther Recent Offeringsrn1. Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030rn2. Medical Device Contract Manufacturing Market, 2019-2030rn3. Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closuresrn4. Biopharma Contract Manufacturing Market (3rd Edition), 2019 – 2030rn5. Patient Recruitment and Retention Services Market, 2019-2030rnrnAbout Roots AnalysisrnRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] InformationrnRoots Analysis Private LimitedrnGaurav Chaudharyrn+1 (415) 800 [email protected] https://www.rootsanalysis.com/reports/view_document/biologics-fill–finish-services-market/256.html

The at-home blood collection and micro sampling devices market is projected to grow at a CAGR of 10.7%, claims Roots Analysis

Roots Analysis has announced the addition of “At-Home Blood Collection and Micro Sampling Devices market, 2021-2030” report to its list of offerings.rnrnThe report features an extensive study of the current market landscape and the likely adoption of at-home self-blood collection and micro sampling devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report features:rn A detailed overview of the current market landscape of at-home self-blood collection and micro sampling devices, along with information on several relevant parametersrn Elaborate profiles of key players engaged in this domain. Each company profile features a brief overview of the companyrn An in-depth product competitiveness analysis of at-home blood collection and micro sampling devicesrn A detailed analysis of various patents that have been filed / granted within this domain, since 2015. The analysis assesses several relevant parameters associated with the patentsrn An analysis of the recent partnerships inked between various players engaged in this domain, during the period 2014-2021 rn A detailed analysis of various investments made by players engaged in this domain, based on several relevant parametersrn An insightful analysis highlighting the cost saving potential associated with at-home self-blood collection and micro sampling devices, taking into consideration several relevant parameters. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)rn Blood Sample Statern Dried Blood Samplern Liquid Blood Samplern Method of Sample Collectionrn Fingerstick Methodrn Push-button Methodrn Area of Applicationrn Diagnosticsrn Researchrn Therapeuticsrn Othersrn Geographical Region rn North Americarn Europern Asia-PacificrnrnKey companies covered in the reportrn EUROIMMUNrn Everlywell rn Labcorprn Labonovomrn LameditechrnrnFor more information please click on the following link:rnhttps://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market rnrnOther Recent Offeringsrn1. Teleradiology Services: Industry Trends and Global Forecasts, 2021-2030rn2. Telemedicine Tools and Software Providers Market: Industry Trends and Global Forecasts, 2021-2030rn3. Global Pharmaceutical Vials Market: Industry Trends and Global Forecasts, 2021-2030 rn4. Large Volume Wearable Injectors Market: Industry Trends and Global Forecasts, 2021-2030rnrnAbout Roots AnalysisrnRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] InformationrnRoots Analysis Private LimitedrnBen Johnson rn+1 (415) 800 3415rn+44 (122) 391 [email protected] rn https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

The CD-47 targeting therapeutics market is estimated to be worth USD 7.1 billion in 2035, predicts Roots Analysis

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD-47 as an effective biomarker for the diagnosis and treatment purposesrnrnRoots Analysis is pleased to announce the publication of its recent study, titled, “CD-47 Targeting Therapeutics Market, 2021-2035.”rnrnThe report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of CD47 targeting therapeutics in the healthcare industry, over the next 15 years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:rn A detailed assessment of the current market landscape of drug developers engaged in the development of CD-47 targeting therapeutics market. rn Detailed profiles of developers of CD-47 targeting therapeutics developers (shortlisted on the basis of our proprietary scoring criteria).rn A detailed analysis of more than 70 completed, ongoing and planned clinical studies of CD-47 targeting therapeutics domain.rn A detailed review of close to 600 peer-reviewed, scientific articles related to research on CD47 targeting therapies. rn An analysis of the partnerships that have been established in this domain, in the recent past.rn An analysis of the funding and investments that have been carried out in this domain, in the recent past.rn An analysis highlighting the key opinion leaders (KOLs) in this domain.rn An analysis highlighting various social media trends (Facebook).rn A competitiveness analysis of companies, featuring insightful pictorial summaries and representations.rn An analysis of the initiatives of big biopharma players engaged in this domain.rn An analysis of the various start-ups engaged in this domain.rn A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)rn Target Disease Indication rn Acute Myeloid Leukemiasrn Non-Hodgkin Lymphomarn Colorectal Cancersrn Diffuse Large B-Cell Lymphomarn Myelodysplastic Syndromesrn Non-Small Cell Lung Cancersrn Ovarian Epithelial Cancerrn Oral Muscositisrn Small Cell Lung Cancersrn Type of Moleculern Biologicsrn Small Moleculesrn Key Geographical Region rn USrn Francern Germanyrn Italyrn Spainrn UKrn Australiarn Chinarn Indiarn IsraelrnrnKey companies covered in the reportrn ALX Oncologyrn Conjupro Biotherapeuticsrn EpicentRxrn Forty Sevenrn Innovent Biologicsrn KAHR Medicalrn Trillium TherapeuticsrnrnFor more information please click on the following link:rnhttps://www.rootsanalysis.com/reports/cd-47-targeting-therapeutics-market.htmlrnrnYou may also be interested in the following titles: rn1. RAS Targeting Therapies Market, 2021-2031rn2. Squamous NSCLC Market, 2021-2031rn3. Peptide Therapeutics Market, 2021-2031rnrnAbout Roots AnalysisrnRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] InformationrnRoots Analysis Private LimitedrnBen Johnson rn+1 (415) 800 3415rn+44 (122) 391 [email protected] https://www.rootsanalysis.com/reports/cd-47-targeting-therapeutics-market.html

The biopreservation media providers market is projected to grow at an annualized rate of 23.57%, during the period 2021-2035, claims Roots Analysis

rnRoots Analysis has announced the addition of “Biopreservation Media Providers Market, 2021-2035” report to its list of offerings.rnrnThe report features an extensive study of the current market landscape and future potential of the players engaged in offering biopreservation media. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:rnrn A detailed assessment of the current market landscape of biopreservation media offered by the companies. It also includes the service providers landscape of the biopreservation media providers.rn An in-depth company competitiveness analysis of biopreservation media providers, taking into consideration various company specific parameters. rn Elaborate profiles of key industry players that are currently engaged in offering biopreservation media.rn An analysis of the partnerships that have been inked by stakeholders in this area, during the period between 2015 and 2021.rn A Bowman’s strategy clock framework to understand the pricing strategy of the biopreservation media offered by the company along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the biopreservation media based upon its characteristics.rn A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)rnrn Preservation Condition rn Cryogenic / LN2 Vapor Phase rn Frozen (Ultra-Low) / Deep Frozenrn Frozen / Cold ChainrnRefrigeratedrn Type of Serumrn Fetal Bovine Serum Containing Mediarn Fetal Calf Serum Containing Media rn Human Serum Containing Mediarn Serum Free Media rnrn Type of Biological Samplern Germline Cells / Stem Cellsrn Organsrn Somatic Cellsrn Tissuesrnrn Area of Applicationrn Diagnostic Usern Research and Development rn Therapeutic Usernrn Type of Packaging Formatrn Bagsrn Bottlesrn Vialsrn Othersrnrn End Usersrn Academic and Research Institutes rn Biobanks / Genebanks rn Hospitalsrn Pharmaceutical and Biotechnology Companiesrn Other End Usersrnrn Regionrn North Americarn Europern Asiarn MENArn Latin Americarn Rest of the WorldrnrnKey companies covered in the reportrn BioLife Solutionsrn Cell Applicationsrn HiMedia Laboratoriesrn Merckrn Thermo Fischer Scientificrn United States Biologicalrn ZenBiornrnFor more information, please click on the following link:rnhttps://www.rootsanalysis.com/reports/biopreservation-media-providers-market.htmlrnrnOther Recent Offeringsrn1. Cell and Gene Therapy Bioassay Services Market, 2021-2030rn2. Cell Therapy Consumables / Cell Culture Media / Cell Isolation Kits / Cell Therapy Manufacturing Reagents Market, 2021-2030rn3. Cell Therapy Manufacturing Market (4th Edition), 2021-2030rnrnAbout Roots AnalysisrnRoots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] InformationrnRoots Analysis Private LimitedrnBen Johnsonrn+1 (415) 800 3415rn+44 (122) 391 [email protected] rn https://www.rootsanalysis.com/reports/biopreservation-media-providers-market.html

THE RISING REALM: BIOPRESERVATION MEDIA INDUSTRY

Biopreservation is the exclusive biological approach designated for the preservation of cells, tissues and organs ex-vivo for the purpose of storage, shipment and transportation. Biopreservation media is one of the most crucial entity in conferring effectiveness. The selection of the type of media depends upon the considerable time duration desired for the storage, type of biological material to be preserved and the purpose of biopreservation. The optimal biopreservation media should lead to good cell recovery, cell viability and no compromise in the functioning, post preservation and thawing. Depending upon the temperature range for effective preservation, biopreservation media is classified into media for hypothermic preservation and biopreservation media for cryopreservation. https://www.rootsanalysis.com/blog/the-rising-realm-biopreservation-media-industry/

Regulatory T-cell Therapies: A Research Hotspot in the Field of Immunotherapy

The Regulatory T-Cell Therapies (Tregs) are a mature subpopulation of T-cells that play a critical role in mediating immunological tolerance to self-antigens and suppress immune responses that are harmful to the host, thereby, enabling homeostasis. These mainly develop in thymus from CD4+ thymocytes and are mainly of three types: natural Tregs, adaptive Tregs and invitro Tregs. Tregs can either be directly administered or can be transduced with T cell receptor (TCR) or chimeric antigen receptor (CAR) which have high affinity to target antigens. In recent years, Treg based therapies have become a research hotspot in the field of immunotherapy due to their ability to prevent / delay graft rejection and control autoimmune responses generated post adoptive transfer in vivo. https://www.rootsanalysis.com/blog/regulatory-t-cell-therapies-a-research-hotspot-in-the-field-of-immunotherapy/

Myeloid Cell Targeting Therapies: Budding Therapy Against Cancer

The global cancer burden is increasing rapidly with over 19 million new cancer cases and 10 million deaths reported in the year 2020. Given the rising prevalence, researchers have made significant efforts in discovering new approaches for the treatment of oncological diseases. With several programs having entered the clinical stages, myeloid cell targeting therapies have emerged as a novel strategy in the suite of cancer immunotherapy approaches.rnrnAll the blood and immune cells are formed from the hematopoietic stem cell, with multiple stepwise intermediates. The hematopoietic hierarchy is divided into two primary branches: the myeloid cells and lymphoid cells. https://www.rootsanalysis.com/blog/myeloid-cell-targeting-therapeutics-budding-therapy-against-cancer/